Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02197338 · ClinicalTrials.gov registry record · NA
Randomized Trial of Wire and Sphincterotome Systems for Biliary Cannulation
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 498
- Enrollment target
NCT02197338 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 498 participants.
The verdict
NCT02197338, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 498 participants
- Enrollment target
Study Summary
1. Cannulation of (placement of a small catheter into) the bile duct is critical to remove bile duct stones, divert bile leaks, and decompress biliary obstruction due to cancer. 2. Given the small size of the bile duct orifice and its close proximity to the pancreatic duct, selective biliary cannulation is the most difficult part of the endoscopic retrograde cholangiography (ERCP). 3. New small diameter sphincteromes and "short wire" systems (which allow physicians to control guidewires) offer potential, though untested advantages. 4. At most hosptial both the long and short wire systems as well as small versus standard are routinely used for clinical care. 5. Our hypothesis is that small diameter, physician controlled wires favor biliary cannulation 6. Our objective will be to assess whether small diameter sphincterotomes and "short wire" physician controlled guidewire cannulation favors successful bile duct cannulation and minimize complications.
Interventions
- OTHER Bile Duct Cannulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02197338
The ClinicalTrials.gov registry entry for NCT02197338 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 498 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bile Duct Cannulation is the first listed.
NCT02197338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02197338 about?
NCT02197338 is a clinical study titled "Randomized Trial of Wire and Sphincterotome Systems for Biliary Cannulation". 1. Cannulation of (placement of a small catheter into) the bile duct is critical to remove bile duct stones, divert bile leaks, and decompress biliary obstruction due to cancer. 2. Given the small size of the bile duct orifice and its close proximity to the pancreatic duct, selective biliary cannula...
What is the current status of trial NCT02197338?
This trial is currently completed. It is a NA study. The enrollment target is 498 participants. The study started on 2016-04. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02197338?
The interventions under investigation include: Bile Duct Cannulation (OTHER).
Who is sponsoring clinical trial NCT02197338?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.